Remove 2001 Remove Documentation Remove Vaccines
article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

Through this outcomes measurement tool, patients keep comprehensive diaries of their condition, documenting what aspects of the disease affect them most. He joined Johnson & Johnson in 2001 as Director Corporate Communications. Let their voice be the driving force in our shared goal of making disease a thing of the past.

article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Complete Data Gathering. Outline Guiding and Segregation Principles.